Results 11 to 20 of about 379 (76)

Assessment of Clinical, Histopathological, and Bacteriological Findings in Treated Leprosy Patients with Persistent Skin Lesions: A Retrospective Cohort Study. [PDF]

Am J Trop Med Hyg, 2023
Patial M, Hanumanthu V, Chhabra S, Singh I, Chatterjee D, Narang T, Dogra S.   +6 more
europepmc   +1 more source

Presence of Viable Bacilli in Multibacillary Leprosy After 12 Doses of Multidrug Therapy. [PDF]

Rev Soc Bras Med Trop
Assis DR, Barreto JG, Gaggini MCR, Damazo AS, Fontes CJF, Florian MC.   +5 more
europepmc   +1 more source

An alternative multidrug regimen for multibacillary Hansen's disease: a case report. [PDF]

J Med Case Rep
Akhverdyan N, Cantor Z, Hawkins K.
europepmc   +1 more source

Clofazimine-induced skin pigmentation. [PDF]

Pan Afr Med J
Karnan A, Ledwani A.
europepmc   +1 more source

Association of PTX3 gene polymorphisms and PTX3 plasma levels with leprosy susceptibility. [PDF]

BMC Infect Dis, 2023
Moraes ACCG, da Luz RCFV, Fernandes ALM, Barbosa MXS, de Andrade LV, Armstrong ADC, de Souza CDF, do Carmo RF.   +7 more
europepmc   +1 more source

A type 1 leprosy reaction in a 50-year-old man. [PDF]

CMAJ
Richard-Greenblatt M, Stryjewska B, Kalina DR.   +2 more
europepmc   +1 more source

[Leprosy epidemiology in Daoukro health district (Côte d'Ivoire) from 1999 to 2017]. [PDF]

Med Trop Sante Int, 2023
Tetchi EOS, Konan YE, Kpebo D, Djoman MC, Ekou FK, Sable PS, Yapi A, Tano-Ake O.   +7 more
europepmc   +1 more source

Classic and new candidate markers for drug resistance in a large cohort of leprosy patients from the Amazon state, Brazil. [PDF]

Antimicrob Agents Chemother
Ferrreira CdO, Leturiondo AL, Dos Santos CG, da Silva JB, Souza MFdA, Rego CBO, de Souza GC, Pinheiro TB, Melo GC, Rosa PS, Mira MT, Avanzi C, Talhari C.   +12 more
europepmc   +1 more source

Tuberculous spondylitis following intravesical Bacillus Calmette-Guérin therapy for bladder cancer surgically treated through the anterior approach. [PDF]

BMJ Case Rep, 2022
Shimizu T, Kobayashi Y, Fujiyoshi K, Yato Y.   +3 more
europepmc   +1 more source

Assessment of TB47 as a potential novel therapeutic agent: <i>in vitro</i> and <i>in vivo</i> efficacy against <i>Mycobacterium leprae</i>. [PDF]

Antimicrob Agents Chemother
Furlan GHF, Oliveira DAS, Bertoluci DFDF, Gomes TA, Perico J, Martins BL, Do Nascimento DC, Diorio SM, Soares CT, Wang S, Zhang T, Rosa PS, Lara FA, Pereira Latini AC.   +13 more
europepmc   +1 more source